Literature DB >> 2500220

Retroperitoneal fibrosis in a patient with macroprolactinoma treated with bromocriptine.

A Herzog1, H Minne, R Ziegler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2500220      PMCID： PMC1836500          DOI： 10.1136/bmj.298.6683.1315-a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Pleuropulmonary and retroperitoneal fibrosis associated with bromocriptine treatment.

Authors:  C D Ward; J Thompson; M D Humby
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-12       Impact factor: 10.154

2.  Retroperitoneal fibrosis and treatment of Parkinson's disease with high doses of bromocriptine.

Authors:  J F Demonet; M Rostin; J M Dueymes; A Ioualalen; J L Montastruc; A Rascol
Journal:  Clin Neuropharmacol       Date:  1986       Impact factor: 1.592

3.  Retroperitoneal fibrosis and bromocriptine.

Authors:  J V Bowler; I E Ormerod; N J Legg
Journal:  Lancet       Date:  1986-08-23       Impact factor: 79.321
  3 in total
  1 in total

Review 1.  Classical dopamine agonists.

Authors:  R Horowski; P-A Löschmann
Journal:  J Neural Transm (Vienna)       Date:  2019-02-25       Impact factor: 3.575
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.